LumiThera Completes Patient Enrollment In the LIGHTSITE III Clinical Study

The randomized, multi-center study, LIGHTSITE III, enrolled the last patient at the Byers Eye Institute at Stanford University in Palo Alto, CA with Principal Investigator, Diana Do, M.D. 

This is a content summary only. Visit us at https://infomeddnews.com

This is not a CAPTIS article. Originally, it was published here.